Uplizna 100 mg/10ml

Uplizna 100 mg/10ml is a medicine authorised by Swissmedic under authorisation number 69322. The authorisation holder is Amgen Switzerland AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 04 March 2024 and the authorisation is limited until 03 March 2029. ATC code L04AA47 places the medicine in the group Immunosuppressants.

  • Dispensing category A
  • Authorisation number 69322
  • ATC L04AA47
  • Biotechnological medicines
Authorisation data
Authorisation number69322
NameUplizna 100 mg/10ml
Full nameUplizna 100 mg/10ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderAmgen Switzerland AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL04AA47
First authorisation04 March 2024
Authorisation validity03 March 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Uplizna 100 mg/10ml, Konzentrat zur Herstellung einer InfusionslösungA04 March 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
13Durchstechflasche(n)L04AA4707.15.0.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Uplizna 100 mg/10ml authorised in Switzerland?

Yes. Uplizna 100 mg/10ml is authorised by Swissmedic under authorisation number 69322, data as of 01 September 2026. The authorisation is limited until 03 March 2029.

Which dispensing category does Uplizna 100 mg/10ml have?

Uplizna 100 mg/10ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Uplizna 100 mg/10ml?

The authorisation holder is Amgen Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com